Reproductive Quiz #37, Estrogen Receptor Modulators and Aromatase Inhibitors

1. A 55-year-old postmenopausal woman with a history of hormone receptor-positive breast cancer is being considered for adjuvant therapy to reduce the risk of recurrence. Which of the following medications is most appropriate for this patient to prevent the conversion of androgens to estrogens? 

Question 1 of 5

2. A 62-year-old woman with a history of osteoporosis and a high risk of developing breast cancer is discussing preventive options with her doctor. Which of the following medications not only reduces the risk of breast cancer but also has a beneficial effect on bone density?

Question 2 of 5

3. A 48-year-old premenopausal woman is diagnosed with hormone receptor-positive, HER2-negative breast cancer. She undergoes a lumpectomy followed by radiation therapy. Which of the following medications is most appropriate for her hormonal therapy, considering her premenopausal status?

Question 3 of 5

4. A postmenopausal woman with advanced hormone receptor-positive breast cancer has progressed despite initial treatment with an aromatase inhibitor. Which of the following medications would be most appropriate to initiate as a second-line therapy in this patient?

Question 4 of 5

5. A 50-year-old woman with metastatic breast cancer is currently being treated with letrozole, an aromatase inhibitor. She complains of significant joint pain since starting the medication. Which of the following is a common side effect of aromatase inhibitors that may explain her symptoms? 

Question 5 of 5


 

¡Por tiempo limitado!

Unete a nuestro boletín mensual y obtén todos nuestros talleres USMLE/ECFMG ¡GRATIS! (+100 videos)

¡Únete a nuestra comunidad de IMGs!

¡Obtén actualizaciones mensuales USMLE y ECFMG, además, obtén un taller USMLE gratis al instante!

"Taller 01: ¿Qué es el USMLE?”

Taller Gratuito USMLE

Este taller proporciona un análisis en profundidad de todos los exámenes USMLE, consejos para tomar exámenes y cómo estudiar de manera efectiva.

OFERTA POR TIEMPO LIMITADO

Especialista ECFMG: Dr. Carla Rebeca Lainez Casal

Facultad de Medicina: Universidad Catholica de Santiago de Guayaquil
ECFMG Certification date: October 13, 2022.
Residency: 2023 Internal Medicine Applicant
+1 7542724970